Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes

Gianluca Iacobellis, Carlos A. Penaherrera, Luis E. Bermudez, Ernesto Bernal Mizrachi

Research output: Contribution to journalArticle

Abstract

Diabetes emerged as major risk factor for severe acute respiratory syndrome (SARS) and adverse outcome in patients with the coronavirus disease 2019 (COVID-19). Nevertheless, the role of admission hyperglycemia in patients with COVID-19 has not been well-explored, yet. With this retrospective analysis, we report for the first time that hyperglycemia on day-1 is the best predictor of radiographic imaging of SARS-CoV2, regardless of the past medical history of diabetes. Admission hyperglycemia should not be overlooked, but adequately treated to improve the outcomes of COVID-19 patients with our without diabetes.

Original languageEnglish (US)
Number of pages1
JournalDiabetes research and clinical practice
Volume164
DOIs
StatePublished - Jun 1 2020

Keywords

  • COVID-19
  • Diabetes
  • Hyperglycemia
  • SARS-Cov2

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes'. Together they form a unique fingerprint.

  • Cite this